Literature DB >> 22440822

Patient and provider barriers to effective management of gout in general practice: a qualitative study.

Karen Spencer1, Alison Carr, Michael Doherty.   

Abstract

OBJECTIVES: To explore patient and provider illness perceptions and barriers to effective management of gout in general practice. DESIGN AND
SETTING: A qualitative study involving semistructured face-to-face interviews with patients and health professionals from 25 Nottinghamshire general practices and one central National Health Service hospital. PARTICIPANTS: Twenty gout sufferers and 18 health professionals (six general practitioners, five hospital physicians, seven practice nurses).
RESULTS: A number of key themes emerged suggesting that several factors impact on patients' access to recommended treatments. The main barriers were patient experiences and lay beliefs of their condition which affected seeking advice and adherence to treatment. There was universal lack of knowledge and understanding of the causes and consequences of gout and that it can be treated effectively by lifestyle change and use of urate lowering therapy (ULT). All participants associated gout with negative stereotypical images portrayed in Victorian cartoons. Many viewed it as self-inflicted or part of ageing and only focused on managing acute attacks rather than treating the underlying cause. The main provider barriers that emerged related to health professionals' lack of knowledge of gout and management guidelines, reflected in the suboptimal information they gave patients and their reluctance to offer ULT as a 'curative' long-term management strategy.
CONCLUSION: There are widespread misconceptions and lack of knowledge among both patients and health professionals concerning the nature of gout and its recommended management, which leads to suboptimal care of the most common inflammatory joint disease and the only one for which we have 'curative' treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22440822     DOI: 10.1136/annrheumdis-2011-200801

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  68 in total

1.  Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.

Authors:  David Bursill; William J Taylor; Robert Terkeltaub; Masanari Kuwabara; Tony R Merriman; Rebecca Grainger; Carlos Pineda; Worawit Louthrenoo; N Lawrence Edwards; Mariano Andrés; Ana Beatriz Vargas-Santos; Edward Roddy; Tristan Pascart; Ching-Tsai Lin; Fernando Perez-Ruiz; Sara K Tedeschi; Seoyoung C Kim; Leslie R Harrold; Geraldine McCarthy; Nitin Kumar; Peter T Chapman; Anne-Kathrin Tausche; Janitzia Vazquez-Mellado; Marwin Gutierrez; Geraldo da Rocha Castelar-Pinheiro; Pascal Richette; Eliseo Pascual; Mark C Fisher; Ruben Burgos-Vargas; Philip C Robinson; Jasvinder A Singh; Tim L Jansen; Kenneth G Saag; Ole Slot; Tillmann Uhlig; Daniel H Solomon; Robert T Keenan; Carlo Alberto Scire; Edyta Biernat-Kaluza; Mats Dehlin; George Nuki; Naomi Schlesinger; Matthijs Janssen; Lisa K Stamp; Francisca Sivera; Anthony M Reginato; Lennart Jacobsson; Frédéric Lioté; Hang-Korng Ea; Ann Rosenthal; Thomas Bardin; Hyon K Choi; Michael S Hershfield; Christine Czegley; Sung Jae Choi; Nicola Dalbeth
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-03       Impact factor: 4.794

2.  Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?

Authors:  Matthew J Coleshill; Eindra Aung; Jane E Carland; Kate Faasse; Sophie Stocker; Richard O Day
Journal:  Ther Innov Regul Sci       Date:  2020-07-13       Impact factor: 1.778

Review 3.  Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications.

Authors:  Sebastian E Sattui; Angelo L Gaffo
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-05-02       Impact factor: 5.346

Review 4.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

5.  Poorly controlled gout: who is doing poorly?

Authors:  Faith Li-Ann Chia
Journal:  Singapore Med J       Date:  2016-08       Impact factor: 1.858

6.  Crystal arthritis: New recommendations highlight the need for more research.

Authors:  Naomi Schlesinger
Journal:  Nat Rev Rheumatol       Date:  2016-09-09       Impact factor: 20.543

Review 7.  Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?

Authors:  Zahira Latif; Abhishek Abhishek
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

8.  Research priorities in gout: the patient perspective.

Authors:  Jasvinder A Singh
Journal:  J Rheumatol       Date:  2014-03       Impact factor: 4.666

9.  Goals of gout treatment: a patient perspective.

Authors:  Jasvinder A Singh
Journal:  Clin Rheumatol       Date:  2018-08-04       Impact factor: 2.980

10.  Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT.

Authors:  Chio Yokose; Nicola Dalbeth; Jie Wei; Savvas Nicolaou; F Joseph Simeone; Scott Baumgartner; Maple Fung; Yuqing Zhang; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2019-07-11       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.